Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$41.33 - $74.26 $312,124 - $560,811
7,552 Added 52.46%
21,948 $927 Million
Q1 2024

May 16, 2024

BUY
$56.27 - $73.77 $464,171 - $608,528
8,249 Added 134.2%
14,396 $994 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $405,333 - $608,798
6,147 New
6,147 $419 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track La Banque Postale Asset Management Sa Portfolio

Follow La Banque Postale Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Banque Postale Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on La Banque Postale Asset Management Sa with notifications on news.